324 related articles for article (PubMed ID: 24361062)
1. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
5. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
Bensmail D; Hanschmann A; Wissel J
J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
[TBL] [Abstract][Full Text] [Related]
7. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
9. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
[TBL] [Abstract][Full Text] [Related]
11. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
14. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
[TBL] [Abstract][Full Text] [Related]
16. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.
Tomášová Z; Hluštík P; Král M; Otruba P; Herzig R; Krobot A; Kaňovský P
J Neuroimaging; 2013 Jul; 23(3):337-44. PubMed ID: 22212022
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
[TBL] [Abstract][Full Text] [Related]
18. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
[TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin type A treatment of upper limb spasticity].
Wissel M; Wissel J
Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
